KYMR Kymera Therapeutics, Inc.
Executive Summary
A mixed institutional cluster in Kymera Therapeutics for Q4 2025 shows 7 buyers adding $485.7M in net new positions, dominated by passive/index funds (Fidelity, BofA, Wells Fargo, Invesco) alongside two active managers (AllianceBernstein new at $74.1M, Franklin Resources doubling to $27.6M). Four sellers trimmed modestly, led by quant fund Two Sigma (-$3.7M) and Massachusetts Financial Services (-$2.1M). The heavy passive buying likely reflects index rebalancing rather than a fundamental catalyst, while the active manager additions suggest selective conviction in Kymera's protein degradation pipeline.
Key Financial Metrics
Institutional Positions
Net institutional flow: $478.7M
▲ Buyers (7)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Fidelity | ADD | +51.9% | $694.7M | $361.9M |
| Alliancebernstein | NEW | — | $74.1M | $74.1M |
| Franklin Resources | DOUBLED | +1019.9% | $27.6M | $25.8M |
| BofA | ADD | +82% | $26.4M | $15.8M |
| Invesco | ADD | +46.3% | $9.1M | $4.6M |
| Wells Fargo | DOUBLED | +107.4% | $5.2M | $3.4M |
| Mirae Asset Global Investments | ADD | +26.5% | $272.0K | $116.0K |
▼ Sellers (4)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Two Sigma | TRIM | -38.2% | $24.3M | -$3.7M |
| Massachusetts Financial Servic | TRIM | -33.5% | $24.6M | -$2.1M |
| Ameriprise Financial | NEAR_EXIT | -85.8% | $1.4M | -$1.1M |
| Morgan Stanley | TRIM | -27.5% | $21.4M | -$62.1K |
Actionable Insight
The cluster is dominated by passive rebalancing (Fidelity alone accounts for 75% of net buying), which limits the signal's conviction. The active manager additions from AllianceBernstein and Franklin Resources are notable but small relative to the passive flows. Given the 14% historical win rate on KYMR reports and negative alpha, traders should treat this as noise unless a specific pipeline catalyst (e.g., clinical data readout) emerges. Monitor upcoming 13F filings for unwinding of these positions.
Key Facts
- 7 buyers added $485.7M in net new positions; 4 sellers reduced by $6.9M
- Fidelity added 3.05M shares (+51.9%), now holding $694.7M — the dominant buyer
- AllianceBernstein initiated a new $74.1M position, the largest active-manager entry
- Franklin Resources nearly 11x'd its stake (+1019.9%) to $27.6M
- Two Sigma trimmed 38.2% of its position (-$3.7M), the largest seller by dollar value
- Morgan Stanley trimmed only 27.5% (-$62K), a negligible reduction
- 5 of 7 buyers are mega-passive/index funds; only 2 are active asset managers
- Historical T+20 win rate on KYMR reports is 14% with avg alpha -9.46% vs SPY
Financial Impact
Net institutional buying of $478.7M ($485.7M bought vs $6.9M sold) across 11 filers
Risk Factors
- 45-day 13F reporting lag means positions may already be unwound
- Passive-dominated cluster provides weak directional signal
- Historical KYMR reports show negative alpha at T+20 (-9.46% avg vs SPY)
- Two Sigma's trim suggests quantitative models are reducing exposure
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-KYMR-2025-Q4 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
2d ago
|
Press Release
| $82.96 awaiting T+5 | awaiting T+5 | — | — |
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $82.43 awaiting T+5 | awaiting T+5 | — | — |
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $79.19 awaiting T+5 | awaiting T+5 | — | — |
|
Jun 8, 2026
6d ago
|
Press Release
| $73.80 awaiting T+5 | awaiting T+5 | — | — |
|
May 26, 2026
19d ago
|
144
| $81.70 $73.21 | ▼ −10.39% | ▼ −10.86% | — |
|
May 15, 2026
4w ago
|
Press Release
| $82.21 $78.89 | ▼ −4.04% | ▼ −5.00% | — |
|
May 11, 2026
4w ago
|
144
| $83.55 $79.67 | ▼ −4.64% | ▼ −4.72% | — |
|
Apr 23, 2026
7w ago
|
Press Release
| $87.17 $81.51 | ▼ −6.49% | ▼ −7.97% | — |
|
Apr 15, 2026
8w ago
|
144
| $86.14 $87.17 | ▲ +1.20% | ▲ +0.21% | — |
|
Apr 15, 2026
8w ago
|
144
| $86.14 $87.17 | ▲ +1.20% | ▲ +0.21% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access